• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

One Health. A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy

tetano

Editor, Senior Moderator
One Health. 2020 Apr 19:100135. doi: 10.1016/j.onehlt.2020.100135. [Epub ahead of print]
A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy.


Lorusso A[SUP]1[/SUP], Calistri P[SUP]1[/SUP], Mercante MT[SUP]1[/SUP], Monaco F[SUP]1[/SUP], Portanti O[SUP]1[/SUP], Marcacci M[SUP]1[/SUP], Camm? C[SUP]1[/SUP], Rinaldi A[SUP]1[/SUP], Mangone I[SUP]1[/SUP], Di Pasquale A[SUP]1[/SUP], Iommarini M[SUP]2[/SUP], Mattucci M[SUP]3[/SUP], Fazii P[SUP]4[/SUP], Tarquini P[SUP]5[/SUP], Mariani R[SUP]6[/SUP], Grimaldi A[SUP]7[/SUP], Morelli D[SUP]1[/SUP], Migliorati G[SUP]1[/SUP], Savini G[SUP]1[/SUP], Borrello S[SUP]8[/SUP], D'Alterio N[SUP]1[/SUP].

Author information




Abstract

The current pandemic is caused by a novel coronavirus (CoV) called SARS-CoV-2 (species Severe acute respiratory syndrome-related coronavirus, subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae). In Italy, up to the 2nd of April 2020, overall 139,422 confirmed cases and 17,669 deaths have been notified, while 26,491 people have recovered. Besides the overloading of hospitals, another issue to face was the capacity to perform thousands of tests per day. In this perspective, to support the National Health Care System and to minimize the impact of this rapidly spreading virus, the Italian Ministry of Health involved the Istituti Zooprofilattici Sperimentali (IZSs), Veterinary Public Health Institutes, in the diagnosis of SARS-CoV-2 by testing human samples. IZSAM, is currently testing more than 600 samples per day and WGS from positive samples. Sequence analysis of these samples suggested that outbreaks in Abruzzo region may be related to outbreaks of northern Italy and northern Europe, these latter as for the presence of mutations in the N protein. CoVs, and related diseases, are well known to veterinarians since decades. The experience that veterinarians operating within the Public health system gained in the control and characterization of previous health issues of livestock and poultry including avian flu, bluetongue, foot and mouth disease, responsible for huge economic losses, is certainly of great help to minimize the impact of this global crisis.
? 2020 The Authors. Published by Elsevier B.V.



KEYWORDS:

COVID-19; Molecular characterization; Mutations; Next generation sequencing; One health; SARS-CoV-2; Variants; Veterinarians


PMID:32313828PMCID:PMC7166304DOI:10.1016/j.onehlt.2020.100135
 
Back
Top Bottom